K V Pharmaceutical Co. Class A (NYSE:KV-A)
CAPS Rating:
Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.
RSS Headlines
Fool UK
Recs
Very important new drug could save millions on premies..should be a standard for high risk women